Alzheimer’s disease

BioStock: Alzinova’s CEO - “we are a top actor in the Alzheimer’s field”

Alzinova’s CEO: “We are a top actor in the Alzheimer’s field”

Alzinova has appointed board member Dr Carol Routledge as acting CEO. The move comes as the company continues its...

Intervju
Alzinova's CMO wants to bring forward a vaccine against Alzheimer's

Alzinova’s CMO wants to bring forward a vaccine against Alzheimer’s

Last fall, Dr Kirsten Harting joined Alzinova as...

Intervju
Kristina Torfgård, vd Alzinova

Inlösen av Alzinovas TO3 kan tillföra 28 Mkr

Alzinova, som utvecklar Alzheimervaccinet ALZ-101, är just nu...

Intervju
Alzinova presenterade lovande data vid internationell konferens

Alzinova presenterade lovande data vid internationell konferens

Alzinovas medgrundare och Chief Scientific Officer Anders Sandberg...

Intervju

BioStock Studio: Gabather gives clinical trial update

Gabather’s top candidate GT-002 for treating psychiatric or...

BioStock TV
Intervju

Gabather – focus on CNS diseases

Diseases of the central nervous system (CNS) and...